Affimed N.V., a clinical-stage biopharmaceutical company focused on discovering and developing targeted cancer immunotherapies, in its at-the-market offering of $50 million common shares
ARYA Sciences Acquisition Corp., a special purpose acquisition company sponsored by Perceptive Advisors and focusing on the healthcare or healthcare related industries, in its $125 million initial public offering
BofA Securities, Inc., J.P. Morgan Securities LLC and Wells Fargo Securities LLC, as representatives of the several underwriters, in connection with Visa’s $4 billion senior notes offering
Bristol-Myers Squibb in its $90 billion acquisition of Celgene and its related $13.4 billion divesture of Celgene’s OTEZLA® program to Amgen
Builders FirstSource in its $400 million senior secured notes offering and $75 million and $350 million add-on offerings
Garnett Station Partners in its sale of Cardinal Memorial Holdings
The Jordan Company in its acquisition of PulseR
Linden Capital Partners in its sale of Flexan
MSD Partners in its acquisition of Woolpert
